Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions

v3.20.2
Related Party Transactions
6 Months Ended
Jun. 30, 2020
Related Party Transactions [Abstract]  
Related Party Transactions

Note 6 — Related Party Transactions

 

During the three and six months ended June 30, 2020 and 2019 the Company incurred the following expenses with the minority shareholders of Lucid Diagnostics Inc.:

 

   

For the three months ended

June 30,

   

For the six months ended  

June 30,

 
    2020     2019     2020     2019  
CWRU patent related fees   $ 27     $ 47     $ 59     $ 78  
Clinical supplies – EsoCheck                 15        
EsoGuard Physician Inventors’ consulting agreements     15       36       53       74  
Stock based compensation expense     6       24       12       48  
Total   $ 48     $ 107     $ 139     $ 200